|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/24 |
| (11) | Patento numeris | 3191513 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15760590.8 |
| Europos patento paraiškos padavimo data | 2015-08-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-07-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-06-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/047357 |
| Data | 2015-08-28 |
| (87) | Numeris | WO 2016/040007 |
| Data | 2016-03-17 |
| (30) | Numeris | Data | Šalis |
| 201462047248 P | 2014-09-08 | US | |
| 201462091150 P | 2014-12-12 | US | |
| 201562168007 P | 2015-05-29 | US | |
| 201562191690 P | 2015-07-13 | US |
| (72) |
BRUSSELLE, Guy, BE
O`BRIEN, Christopher, US
ZANGRILLI, James, US
SHAH, Tushar, US
|
| (73) |
Cephalon, Inc.,
41 Moores Road P.O. Box 4011, Frazer, PA 19355,
US
|
| (54) | USE OF RESLIZUMAB TO TREAT MODERATE TO SEVERE EOSINOPHILIC ASTHMA |
| USE OF RESLIZUMAB TO TREAT MODERATE TO SEVERE EOSINOPHILIC ASTHMA |